Hippocrates Research   Report issue

For profit Phase 2 Phase 3
Founded: Genova Italy (1995)

Organization Overview

First Clinical Trial
2005
NCT00290485
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Hippocrate Research & Development | Hippocrates Research